Shinya Rai

26PUBLICATIONS
172CO-AUTHORS
Rheumatology and arthritisImmunogenetics (incl. genetic immunology)Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 09, 2026
Comparative effectiveness and safety of sarilumab vs JAK inhibitors in late- and younger-onset rheumatoid arthritis.

|Feb 02, 2026
Clonal Complexity Defines Distinct Tumor-Intrinsic Biology and Prognosis in Diffuse Large B-Cell Lymphoma.

Takahiro Haeno, Kazuko Sakai, Shuji Minamoto

|Jan 30, 2026
Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes.

Tomohiro Aoki, Gerben Duns, Shinya Rai

|Jan 04, 2026
Real-world comparative effectiveness of sarilumab versus Janus kinase inhibitors as monotherapy in rheumatoid arthritis.

Yuji Nozaki, Kazuya Kishimoto, Tetsu Itami

|Oct 28, 2025
Antipsychotic Chlorpromazine Suppresses STAT5 Signaling, Overcomes Resistance Mediated by the Gatekeeper Mutation FLT3-ITD/F691L, and Synergizes with Quizartinib in FLT3-ITD-Positive Cells.

Aki Fujii-Hanamoto, Hirokazu Tanaka, Ko Fujimoto

|Sep 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.

Franck Morschhauser, Gilles Salles, Laurie H Sehn

Pageof 5

Frequent Collaborators

5 joint publications

J Luis Espinoza

5 joint publications

Hirokazu Tanaka

5 joint publications

Koji Izutsu

4 joint publications

Kisato Nosaka